EVOLENT HEALTH, INC. 4,500,000 Shares of Class a Common Stock Underwriting Agreement (June 28th, 2017)
EVOLENT HEALTH, INC. 7,000,000 Shares of Class a Common Stock Underwriting Agreement (May 19th, 2017)
In connection with the offering contemplated by this underwriting agreement (this Agreement), the Class A Common Stock to be sold by each Selling Stockholder (i) is currently held directly by such Selling Stockholder, (ii) will be issued by the Company to such Selling Stockholder upon exchange (the Exchange) of Class B common units (each, a Class B LLC Unit) of Evolent Health LLC, a Delaware limited liability company (Evolent Health), held by such Selling Stockholder at a ratio of one Class B LLC Unit, together with one share of Class B Common Stock, for one share of Class A Common Stock of the Company, pursuant to the terms of the Third Amended and Restated Operating Agreement of Evolent Health (the Evolent Health LLC Agreement) dated June 4, 2015, by and among the Company, Evolent Health and the other parties named therein and the terms of the Exchange Agreement (the Exchange Agreement) dated as of June 4, 2015, by and among the Company, Evolent Health, and the
EVOLENT HEALTH, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of December 5, 2016 2.00% Convertible Senior Notes Due 2021 (December 5th, 2016)
INDENTURE dated as of December 5, 2016 between EVOLENT HEALTH, INC., a Delaware corporation, as issuer (the "Company," as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the "Trustee," as more fully set forth in Section 1.01).
EVOLENT HEALTH, INC. 2.00% Convertible Senior Notes Due 2021 Purchase Agreement (December 5th, 2016)
EVOLENT HEALTH, INC. 7,500,000 Shares of Class a Common Stock Underwriting Agreement (September 14th, 2016)
AGREEMENT AND PLAN OF MERGER Among EVOLENT HEALTH, INC., ELECTRA MERGER SUB, LLC, VALENCE HEALTH, INC. And (July 14th, 2016)
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of July 12, 2016, is by and among Evolent Health, Inc., a Delaware corporation ("Evolent"), Electra Merger Sub, LLC, a Delaware limited liability company and wholly-owned subsidiary of Evolent ("Merger Sub" and together with Evolent, collectively, the "Evolent Entities"), Valence Health, Inc., a Delaware corporation ("Valence Parent"), and North Bridge Growth Management Company LLC ("North Bridge") and Philip Kamp, jointly as the Securityholders' Representative (as defined below). Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in Annex A attached hereto.